2017 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
John R. Mascola mainly investigates Virology, Antibody, Virus, Immunology and Neutralization. His Virology study incorporates themes from Epitope, Immune system and Monoclonal antibody. His studies deal with areas such as Molecular biology and Glycoprotein as well as Antibody.
The concepts of his Virus study are interwoven with issues in Immunoglobulin G, Cellular immunity, Immunity, Disease and Chemokine receptor. Immunology and AIDS Vaccines are frequently intertwined in his study. His research investigates the connection between Neutralization and topics such as Binding site that intersect with issues in Receptor.
John R. Mascola focuses on Virology, Antibody, Immunology, Virus and Neutralization. His Virology research is multidisciplinary, incorporating elements of Epitope, Antigen and Immune system. His work investigates the relationship between Epitope and topics such as Glycan that intersect with problems in Glycosylation.
His Antibody study combines topics from a wide range of disciplines, such as Molecular biology, Glycoprotein and Binding site. His studies link AIDS Vaccines with Immunology. John R. Mascola has included themes like Protein structure, Potency and Immunization in his Neutralization study.
John R. Mascola mainly focuses on Virology, Antibody, Neutralization, Virus and Neutralizing antibody. His Virology research is multidisciplinary, incorporating perspectives in Epitope, Immunization, Antigen, Glycoprotein and Pandemic. Antibody is a subfield of Immunology that John R. Mascola studies.
His biological study spans a wide range of topics, including Mutation, Titer, Somatic hypermutation, Priming and Cohort. John R. Mascola interconnects In vitro, Immunogen, Immunity and In vivo in the investigation of issues within Virus. His studies in Monoclonal antibody integrate themes in fields like Viral entry and Internal medicine.
Virology, Antibody, Neutralization, Epitope and Neutralizing antibody are his primary areas of study. The Virology study combines topics in areas such as Immunization, Immunogenicity, Glycoprotein, Severe acute respiratory syndrome coronavirus 2 and Betacoronavirus. His Antibody study integrates concerns from other disciplines, such as Mutation, Virus and Antigen.
His Virus study results in a more complete grasp of Immunology. His research integrates issues of Cell, Somatic hypermutation, Potency and Immune system in his study of Neutralization. His Neutralizing antibody research incorporates themes from Binding domain, Immunogen and Globular protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
John R. Mascola;Gabriela Stiegler;Thomas C. VanCott;Hermann Katinger.
Nature Medicine (2000)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp.
Science (2010)
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
John R. Mascola;Mark G. Lewis;Gabriela Stiegler;Dawn Harris.
Journal of Virology (1999)
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Ming Li;Feng Gao;John R. Mascola;Leonidas Stamatatos.
Journal of Virology (2005)
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang.
Science (2010)
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A Jackson;Evan J Anderson;Nadine G Rouphael;Paul C Roberts.
The New England Journal of Medicine (2020)
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff.
The New England Journal of Medicine (2021)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman.
Nature (2009)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao.
Nature (2013)
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman.
Nature (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
ModeX Therapeutics
National Institutes of Health
National Institutes of Health
National Institutes of Health
Q² Solutions
Scripps Research Institute
Duke University
National Institutes of Health
National Institutes of Health
University of Milan
University of California, Berkeley
Kookmin University
University of California, Riverside
Wuhan University
Oak Ridge National Laboratory
Leibniz Association
Texas Tech University Health Sciences Center
Scripps Research Institute
University of Washington
New York University
University of Tartu
University of Buenos Aires
University of Illinois at Urbana-Champaign
Northwestern University
Stony Brook University